Trials / Conditions / Chronic Idiopathic Thrombocytopenic Purpura
Chronic Idiopathic Thrombocytopenic Purpura
7 registered clinical trials studyying Chronic Idiopathic Thrombocytopenic Purpura — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Special Drug Use-results Survey for Long-term Use (Fostamatinib) NCT06757257 | Kissei Pharmaceutical Co., Ltd. | — |
| Unknown | Safety and Efficacy Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients NCT02614846 | Jiangsu HengRui Medicine Co., Ltd. | Phase 1 |
| Completed | Diagnostic of Chronic Thrombocytopenia NCT04071496 | University Hospital, Bordeaux | — |
| Completed | Clinical Evaluation of SB-497115-GR in Chronic Idiopathic Thrombocytopenic Purpura (ITP) NCT00540423 | GlaxoSmithKline | Phase 3 |
| Completed | A Study to Find How Safe and Effective GAMMAPLEX® is in Subjects With Chronic Idiopathic Thrombocytopenic Purp NCT00504075 | Bio Products Laboratory | Phase 3 |
| Completed | Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytope NCT00441090 | Eisai Inc. | Phase 2 |
| Completed | Helicobacter Pylori Infection in Children With Chronic Idiopathic Thrombocytopenic Purpura NCT00467571 | Mahidol University | Phase 4 |